Applied Radiation Oncology

Actinium Pharmaceuticals to Present Preclinical Efficacy of ATNM-400 at SABCS 2026

🔗📰 Read the article: zurl.co/lUsR2

Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) has revealed that an abstract detailing the preclinical efficacy of ATNM-400 against therapy-resistant breast cancer subtypes will be presented as a poster at the 2026 San Antonio Breast Cancer Symposium (SABCS).

#RadOnc #RadOncNews #RadiationOncology #CancerCare #BreastCancer

🩻 Case Study of the Week - Diagnosis Time!

Stage IIB Testicular Seminoma

🔗 See all the case details, more images, and the diagnosis: zurl.co/7vbqy

#RadOnc #RadiationOncology #CancerCare #CaseStudy #RadOncEd #MedEd #MensHealthAwareness #MensHealthAwarenessMonth

Advancements in Radiotherapy Highlighted at ESTRO 2026

📰🔗 Read the article: zurl.co/dBPMq

Despite the growing body of evidence supporting its efficacy, radiotherapy is underused in several European countries. For instance, only 12–22% of patients eligible for curative treatment receive radiotherapy, as noted in various national registries. This trend was discussed prominently at the ESTRO 2026 congress in Stockholm, emphasizing the need for improved patient awareness.

#RadOnc #RadOncNews #RadiationOncology #CancerCare #ESTRO26 #ESTRO2026

How has postprostatectomy radiation therapy practice changed following NRG-GU003?

🔗 zurl.co/KdtA6

In a retrospective study of 86 patients, researchers examined changes in treatment patterns and geographic reach following publication of NRG-GU003.

The proportion of patients receiving moderately hypofractionated radiation therapy increased from 38% to 71% after March 2024.

While treatment volume and travel distances were numerically greater, further research is needed to determine whether shorter treatment courses improve access to care.

#RadiationOncology #ProstateCancer #ClinicalResearch #MensHealthAwareness #MensHealthAwarenessMonth

ARO BeamOn Podcast: Adaptive Radiotherapy for Pancreatic Cancer

Hosts Jessica Aduwo & Sohil Reddy meet with the Vice Chair and Medical Director of the Department of Radiation Oncology at the Miami Cancer Institute, Dr. Michael Chuong, to discuss the role of radiation therapy in the treatment of locally advanced pancreatic cancer.

🎙️ Listen now: zurl.co/xQzR4

#RadOnc #RadiationOncology #CancerCare #PancreaticCancerAwarenessMonth #PancreaticCancerAwareness #PancreaticCancer